B. Sallerin-Caute

Chronic intrathecal baclofen administration for control of severe spasticity

Y Lazorthes, B. Sallerin-Caute, J.C. Verdié et al. · Journal of neurosurgery · 1990 · 201 citations

Medicine, Neurology, Neurosurgery +17

Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM

H Hanaire-Broutin, B. Sallerin-Caute, Marlène Poncet et al. · Diabetologia · 1996 · 92 citations · Full text

Life Sciences, Biochemistry, Endocrinology +13

CSF Baclofen levels after intrathecal administration in severe spasticity

B. Sallerin-Caute, Y Lazorthes, Bernard Monsarrat et al. · European Journal of Clinical Pharmacology · 1991 · 53 citations

Medicine, Neurology, Neurosurgery +10

Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization.

H Hanaire-Broutin, B. Sallerin-Caute, M F Poncet et al. · PubMed · 1996 · 50 citations

Medicine, Endocrinology, Internal Medicine +17

Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion versus daily injection of recombinant human GH in GH-deficient children.

M. Tauber, H De Bouet Du Portal, B. Sallerin-Caute et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 49 citations

Medicine, Endocrinology, Pediatrics +17